This protocol addresses xeroderma pigmentosum (XP) diagnosed alongside abnormalities of the central and peripheral nervous systems — a clinically distinct presentation that includes XP/CS complex. Neurological involvement substantially affects prognosis and shapes the clinical approach.

Clinical scenario Neurological complications in XP — such as psychomotor retardation — vary in progression and severity, both of which are major determinants of outcome. When XP/CS complex is identified, management follows the guidelines specific to XP neurological disease.

Management approach (partial) When respiratory complications become more frequent in this setting, an airway intervention may form part of the management plan. Full protocol details, clinical criteria, and decision sequence available below →

References

In the majority of Japanese patients, XP is complicated with abnormalities in the central and peripheral nervous systems, such as psychomotor retardations of which progression and severity greatly influence the prognosis.

If the patient is diagnosed with XP/CS complex, conform to the guidelines for XP neurological disease.

If the frequency of respiratory disorder increases, separation of the laryngotracheal tube or tracheotomy might be required.

DOI: 10.1111/1346-8138.13907

View source ↗

Xeroderma Pigmentosum with Central and Peripheral Nervous System Abnormalities

References